SubjectWell Welcomes Danielle Mann as VP of Legal & Compliance

Danielle Mann Joins SubjectWell as New Vice President
SubjectWell, a revolutionary company in the field of patient recruitment, has exciting news regarding its leadership team. The organization proudly announces the appointment of Danielle Mann as the new Vice President of Legal and Compliance. This crucial role will have her manage global legal and compliance operations, which encompass areas such as human resources, contracts, strategic planning, data privacy, and intellectual property. With her expertise, she will spearhead the development of a robust compliance program that aligns with global regulations, further highlighting SubjectWell's commitment to excellence.
Expansive Expertise in Legal Operations
Danielle Mann comes to SubjectWell with over 15 years of experience in corporate law and legal operations. Her significant background includes managing compliance functions for both clinical and pre-clinical studies, navigating SEC filings and corporate governance, as well as contract negotiation. Notably, she has also served as a Data Privacy Officer for global clinical trials, adding substantial depth to her profile.
Endorsement from Leadership
Expressing enthusiasm about her arrival, Fred Martin, the CEO of SubjectWell, shared, "Danielle's extensive background in healthcare legal operations and compliance makes her an exceptional addition to our leadership team. Her proven track record in regulatory compliance, risk management, and global operations aligns perfectly with SubjectWell's commitment to excellence and innovation. This will enhance our capacity to disrupt patient recruitment, doing even more for patients."
Educational Background and Previous Experience
Before taking on the role at SubjectWell, Danielle was instrumental in overseeing legal and compliance operations for several reputable organizations, including Ovid Therapeutics, Cambrex Corporation, Avon Products, and The Hearst Corporation. She holds a Juris Doctor degree from NYU School of Law, a Bachelor of Arts in Pre-Law Studies from Pace University, and a Bachelor of Arts in Management from Towson University. This varied educational foundation further equips her for the challenges she will tackle in her new role.
About SubjectWell
SubjectWell is at the forefront of transforming patient recruitment in clinical trials. The company leverages a unique, comprehensive, and patient-centric technology platform that is significantly enhanced by its growing Patient Network of more than 13 million patients. With a global presence across over 8,800 sites and capabilities spanning more than 600 indications, SubjectWell is dedicated to addressing the most pressing challenges in patient recruitment and clinical development. They stand out with their innovative digital media network and services, which have proven effective in alleviating the burden on clinical sites.
To find out more about their efforts and innovations, visit www.subjectwell.com.
Frequently Asked Questions
What is the purpose of the VP of Legal and Compliance at SubjectWell?
The VP oversees global legal and compliance functions, ensuring the company adheres to all regulations and manages legal risks effectively.
What experience does Danielle Mann bring to her new role?
Danielle Mann has over 15 years of experience in corporate law and legal operations, particularly in compliance for clinical studies and corporate governance.
Who is the CEO of SubjectWell?
Fred Martin is the current CEO of SubjectWell, who has expressed strong support for Danielle Mann's appointment.
What makes SubjectWell stand out in the industry?
SubjectWell is known for its innovative patient-centric technology platform and has a vast network of over 13 million patients, offering solutions to improve patient recruitment.
How can I learn more about SubjectWell?
You can visit their website at www.subjectwell.com for more information about their services and offerings.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.